DiaMedica Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 19 2020 - 9:04AM
Business Wire
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage
biopharmaceutical company focused on developing novel treatments
for chronic kidney diseases and neurological disorders, is pleased
to announce that Rick Pauls, President and CEO of DiaMedica, will
participate in a fireside chat and host one-on-one meetings with
investors at the Piper Sandler 32nd Annual Virtual Growth
Conference. The fireside chat will be available on the Piper
Sandler Conference website to registered attendees on November 23rd
at 10:00 AM ET to December 3, 2020.
The Company will host the one-on-one meetings with investors on
Tuesday, December 1, 2020, meetings can be requested exclusively
via Piper Sandler.
A replay of the fireside chat can be accessed under Events and
Presentations in the Investors section of our website at
https://ir.diamedica.com/events-and-presentations
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage
biopharmaceutical company focused on developing novel treatments
for chronic kidney diseases and neurological disorders. DiaMedica’s
shares are listed on The Nasdaq Capital Market under the trading
symbol “DMAC.”
For more information, please visit www.diamedica.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201119005186/en/
Scott Kellen Chief Financial Officer Phone: (763) 496-5118
skellen@diamedica.com
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Apr 2023 to Apr 2024